Reyes-Uribe, Laura
Wu, Wenhui
Gelincik, Ozkan
Bommi, Prashant V
Francisco-Cruz, Alejandro
Solis, Luisa M
Lynch, Patrick M
Lim, Ramona
Stoffel, Elena M
Kanth, Priyanka http://orcid.org/0000-0001-9303-1516
Samadder, N Jewel
Mork, Maureen E
Taggart, Melissa W
Milne, Ginger L
Marnett, Lawrence J
Vornik, Lana
Liu, Diane D
Revuelta, Maria http://orcid.org/0000-0002-7922-0713
Chang, Kyle
You, Y Nancy
Kopelovich, Levy
Wistuba, Ignacio I
Lee, J Jack
Sei, Shizuko
Shoemaker, Robert H
Szabo, Eva
Richmond, Ellen
Umar, Asad
Perloff, Marjorie
Brown, Powel H
Lipkin, Steven M
Vilar, Eduardo http://orcid.org/0000-0001-6404-3761
Clinical trials referenced in this document:
Documents that mention this clinical trial
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal
mucosa
https://doi.org/10.1136/gutjnl-2020-320946
Documents that mention this clinical trial
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal
mucosa
https://doi.org/10.1136/gutjnl-2020-320946
Documents that mention this clinical trial
Naproxen chemoprevention promotes immune activation in Lynch syndrome colorectal
mucosa
https://doi.org/10.1136/gutjnl-2020-320946
Funding for this research was provided by:
National Cancer Institute (HHSN261201200034I, HHSN261201500039I, P30 CA016672, R01 CA219463)
Feinberg Family Foundation
Emerson Cancer Collective Foundation (ECCRF 192069)